RecruitingNCT06809166
Contrave and diet: short-term brain and metabolic changes
About this title
Read the official source — NCT06809166Medication studyAges 18–64CanadaAnxiety
Understand this study
Who could participate?
Listed age limits: 18 years to 64 years.
- Listed locations
- Ottawa and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 4, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 40
- Sponsor
- The Royal's Institute of Mental Health Research
- Sponsor type
- Research institute
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT06809166
- Official title
Show the full official title
Identifying the Short-Term Neurobiological, Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With Obesity: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Ottawa
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is The Royal's Institute of Mental Health Research, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Contrave and Placebo.
Who can participate?
Listed age limits: 18 years to 64 years.
Is this study still recruiting?
The registry lists this study as recruiting.
